Европейский союз - французский - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Европейский союз - французский - EMA (European Medicines Agency)

mylan ireland limited - fumarate de diméthyle - la sclérose en plaques, sep récurrente-rémittente - immunosuppresseurs - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Европейский союз - французский - EMA (European Medicines Agency)

mylan pharmaceuticals limited - tériflunomide - la sclérose en plaques, sep récurrente-rémittente - immunosuppresseurs - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Канада - французский - Health Canada

mylan pharmaceuticals ulc - rizatriptan (benzoate de rizatriptan) - comprimé (à désintégration orale) - 5mg - rizatriptan (benzoate de rizatriptan) 5mg - selective serotonin agonists

Канада - французский - Health Canada

mylan pharmaceuticals ulc - rizatriptan (benzoate de rizatriptan) - comprimé (à désintégration orale) - 10mg - rizatriptan (benzoate de rizatriptan) 10mg - selective serotonin agonists

Канада - французский - Health Canada

mylan pharmaceuticals ulc - atorvastatine (atorvastatine calcique) - comprimé - 10mg - atorvastatine (atorvastatine calcique) 10mg - hmg-coa reductase inhibitors

Канада - французский - Health Canada

mylan pharmaceuticals ulc - atorvastatine (atorvastatine calcique) - comprimé - 20mg - atorvastatine (atorvastatine calcique) 20mg - hmg-coa reductase inhibitors

Канада - французский - Health Canada

mylan pharmaceuticals ulc - atorvastatine (atorvastatine calcique) - comprimé - 40mg - atorvastatine (atorvastatine calcique) 40mg - hmg-coa reductase inhibitors

Канада - французский - Health Canada

mylan pharmaceuticals ulc - atorvastatine (atorvastatine calcique) - comprimé - 80mg - atorvastatine (atorvastatine calcique) 80mg - hmg-coa reductase inhibitors

Канада - французский - Health Canada

mylan pharmaceuticals ulc - rizatriptan (benzoate de rizatriptan) - comprimé - 5mg - rizatriptan (benzoate de rizatriptan) 5mg - selective serotonin agonists